Association of Known Loci With Lipid Levels Among Children and Prediction of Dyslipidemia in Adults

Background— Recent genome-wide association studies have found 95 distinct genetic loci associated with high-density (HDL-C) and low-density (LDL-C) lipoprotein cholesterol, total cholesterol (TC), and triglycerides (TG), using adult samples. It is not known if these variants are associated with lipid levels in children and adolescents and if the genetic risk score (GRS), based on these variants, could improve adulthood dyslipidemia prediction over the childhood lipid measurements. Methods and Results— We used 2443 participants of the Cardiovascular Risk in Young Finns study cohort with up to 5 measurements of serum lipids taken between ages 3 and 45 years to estimate the effect of individual single-nucleotide polymorphisms and the GRS on lipids. The GRSs were strongly associated with lipids in all age groups (1.5×10−20<P<8.7×10−12 for HDL-C, 3.5×10−27<P<5.6×10−09 for LDL-C, 2.0×10−25<P<5.2×10−09 for TC, and 4.1×10−20<P<8.4×10−05 for TG). Jointly, the lipid loci explained 11.8–26.7% of the total variance in lipids among 3- to 6-year-old children, and the proportion dropped over age, except for TG. The discrimination of adult hypertriglyceridemia improved when GRS was added to childhood lipid measurement (C statistic=0.04, P=0.01). Conclusions— Previously identified lipid loci are associated with lipid levels in children and adolescents and explain up to more than 2 times of the lipid variation in children compared with adults. The TG-GRS improves the risk discrimination over childhood lipid measurement for adult hypertriglyceridemia.

[1]  Shah Ebrahim,et al.  European Guidelines on Cardiovascular Disease Prevention in Clinical Practice (Version 2012) , 2012, International Journal of Behavioral Medicine.

[2]  Michael Inouye,et al.  Founder population-specific HapMap panel increases power in GWA studies through improved imputation accuracy and CNV tagging. , 2010, Genome research.

[3]  S. Kathiresan,et al.  Genetics of coronary artery disease. , 2010, Annual review of genomics and human genetics.

[4]  Sharon R Grossman,et al.  Integrating common and rare genetic variation in diverse human populations , 2010, Nature.

[5]  Tanya M. Teslovich,et al.  Biological, Clinical, and Population Relevance of 95 Loci for Blood Lipids , 2010, Nature.

[6]  T. Lehtimäki,et al.  Follow‐ups of the Cardiovascular Risk in Young Finns Study in 2001 and 2007: Levels and 6‐year changes in risk factors , 2010, Journal of internal medicine.

[7]  M. A. Lasunción,et al.  Sex hormone-binding globulin and lipid profile in pubertal children. , 2010, Metabolism: clinical and experimental.

[8]  Risto Telama,et al.  Cohort profile: the cardiovascular risk in Young Finns Study. , 2008, International journal of epidemiology.

[9]  M. Pencina,et al.  Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond , 2008, Statistics in medicine.

[10]  Shah Ebrahim,et al.  European guidelines on cardiovascular disease prevention in clinical practice: executive summary: Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (Constituted by representatives of nine societies and by invit , 2007, European heart journal.

[11]  R. D'Agostino,et al.  A genome-wide association study for blood lipid phenotypes in the Framingham Heart Study , 2007, BMC Medical Genetics.

[12]  Manuel A. R. Ferreira,et al.  PLINK: a tool set for whole-genome association and population-based linkage analyses. , 2007, American journal of human genetics.

[13]  N. Cook Use and Misuse of the Receiver Operating Characteristic Curve in Risk Prediction , 2007, Circulation.

[14]  J. Viikari,et al.  The 21‐year follow‐up of the Cardiovascular Risk in Young Finns Study: risk factor levels, secular trends and east–west difference , 2004, Journal of internal medicine.

[15]  J. Mckenney,et al.  National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) , 2002 .

[16]  T. Lehtimäki,et al.  Trends in serum lipid levels during 1980-1992 in children and young adults. The Cardiovascular Risk in Young Finns Study. , 1997, American journal of epidemiology.

[17]  E. S. Venkatraman,et al.  A distribution-free procedure for comparing receiver operating characteristic curves from a paired experiment , 1996 .

[18]  J. Viikari,et al.  Tracking and predictiveness of serum lipid and lipoprotein measurements in childhood: a 12-year follow-up. The Cardiovascular Risk in Young Finns study. , 1994, American journal of epidemiology.

[19]  D. Hosmer,et al.  Applied Logistic Regression , 1991 .

[20]  S. Srinivasan,et al.  Tracking of serum lipids and lipoproteins from childhood to adulthood. The Bogalusa Heart Study. , 1991, American journal of epidemiology.

[21]  J. Viikari,et al.  Serum lipids and lipoproteins in children, adolescents and young adults in 1980-1986. , 1991, Annals of medicine.

[22]  P. Wenham,et al.  GENETICS OF CORONARY HEART DISEASE , 1989, The Lancet.

[23]  J. Viikari,et al.  Cardiovascular risk in young Finns, results from the second follow-up study. , 1989, Annals of medicine.

[24]  S. Srinivasan,et al.  Dynamic changes of serum lipoproteins in children during adolescence and sexual maturation. , 1981, American journal of epidemiology.

[25]  B. Edwards,et al.  Lipids and lipoproteins in 927 schoolchildren, ages 6 to 17 years. , 1978, Pediatrics.

[26]  R. Collins,et al.  Common variants at 30 loci contribute to polygenic dyslipidemia , 2009, Nature Genetics.

[27]  Christian Gieger,et al.  Loci influencing lipid levels and coronary heart disease risk in 16 European population cohorts , 2009, Nature Genetics.

[28]  J. Viikari,et al.  Trends in cardiovascular risk factor levels in Finnish children and young adults from the 1970s: The Cardiovascular Risk in Young Finns Study. , 2006, Experimental and clinical cardiology.

[29]  S. Grundy,et al.  National Cholesterol Education Program Third Report of the National Cholesterol Education Program ( NCEP ) Expert Panel on Detection , Evaluation , and Treatment of High Blood Cholesterol in Adults ( Adult Treatment Panel III ) Final Report , 2022 .

[30]  P. de Knijff,et al.  Genetic analysis of sex and generation differences in plasma lipid, lipoprotein, and apolipoprotein levels in adolescent twins and their parents , 1996, Genetic epidemiology.

[31]  K. Berg Genetics of coronary heart disease. , 1983, Progress in medical genetics.